Table 1 Core statistics of the datasets, including clinical tasks and imaging modalities used
Dataset name | Task | Task type | Imaging modality |
|---|---|---|---|
Lung nodule classification | Binary classification | CT | |
Lung nodule classification (conformant to LIDC-IDRI) | Multi-class classification | CT | |
Outcome prediction for non-small cell lung cancer | Survival analysis | CT, PET/CT | |
NSCLC-Radiomics [2] | Outcome prediction for non-small cell lung cancer | Survival analysis | CT |
Classification of lung cancer patients into long/short survival | Binary classification | CT | |
RIDER-Lung-CT [2] | Repeatability of radiomics features for non-small cell lung cancer | Repeatability | CT |
BraTS-2021 [28] | Classification of MGMT promoter methylation status in brain tumor | Classification | MRI |
UCSF-PDGM [29] | Classification of MGMT promoter methylation and IDH mutation status, and outcome prediction in brain tumor | Classification, survival analysis | MRI |
UPENN-GBM [30] | Outcome prediction for glioblastoma | Survival analysis | MRI |
Meningioma-SEG-CLASS [31] | Meningioma grading (grade I vs. II) | Classification | MRI |
LGG-1p19qDeletion [32] | Classification of 1p/19q co-deletion status of low-grade glioma | Classification | MRI |
PI-CAI [33] | Detection of clinically significant prostate cancer | Classification | MRI |
Prostate-MRI-US-Biopsy [34] | Detection of clinically significant prostate cancer | Classification | MRI |
Repeatability of radiomics features in patients with prostate cancer | Repeatability | MRI | |
Head-Neck-Radiomics-HN1 [2] | Outcome prediction for head and neck squamous cell carcinoma | Survival analysis | CT |
Outcome prediction for head and neck squamous cell carcinoma | Survival analysis | CT | |
Head-Neck-PET-CT [39] | Outcome prediction for head and neck cancers | Survival analysis | PET/CT |
OPC-Radiomics [40] | Outcome prediction for oropharynx cancer | survival analysis | CT |
QIN-HEADNECK [41] | Repeatability of radiomics features for head and neck cancers before and after therapy | Repeatability | PET/CT |
Colorectal-Liver-Metastases [42] | Pre-operative outcome prediction for colorectal liver metastases | Survival analysis | CT |
HCC-TACE-Seg [43] | Outcome prediction for hepatocellular carcinoma (HCC) treated with transarterial chemoembolization (TACE) | Survival analysis | CT |
C4KC-KiTS [44] | Kidney tumor segmentation and outcome prediction | Survival analysis | CT |
Soft-tissue-Sarcoma [45] | Lung metastasis detection for sarcoma of the extremity | Binary classification | PET/CT, MRI |
Classification of desmoid-type fibromatosis vs. extremity soft tissue sarcoma | Classification | MRI | |
Classification of malignant vs. benign primary solid liver tumor | Classification | MRI | |
Classification of desmoplastic vs. replacement growth pattern in colorectal liver metastases | Classification | CT | |
Classification of BRAF-mutated vs. BRAF-wild in lung metastases of melanoma | Classification | CT | |
Classification of well-differentiated liposarcoma vs. lipoma | Classification | MRI | |
Classification of gastrointestinal stromal tumor (GIST) vs. tumor resembling GIST | Classification | CT |